Life Sciences Entrepreneurship: UK-HK Perspectives on Innovation and Collaboration

OVERVIEW

Join us for an engaging half-day conference bringing together UK entrepreneurs to share their startup journeys and showcase innovations in AI-driven drug discovery, diagnostics and medical devices, and next-generation therapeutics. A keynote by a serial entrepreneur from Hong Kong will offer valuable insight into local innovation and venture building. Panel discussions, led by veteran investors and entrepreneurs from HK, will delve into the changing landscape of life sciences in both the UK and HK. The event wraps up with a fireside chat focused on the pathways, challenges, and opportunities for collaboration between the UK and Hong Kong.

DATE

12 May 2026 (Tuesday)

TIME

14:00-18:30

VENUE

House Studio, 1/F, Soho House Hong Kong, 33 Des Voeux Road West, Sheung Wan

(Sheung Wan MTR Exit C or Sai Ying Pun MTR Exit A2)

LANGUAGE

English

REGISTRATION

PROGRAMME

14:00-14:30	Registration and Networking
14:30-14:40	Welcome and Opening Remarks Welcome Remarks by Group Chairman or Group CEO, Nan Fung Group Opening Remarks by Mr Chris Woodward, Director General, Trade and Investment, British Consulate General Hong Kong
14:40-15:00	Keynote Address TBC
15:00-15:30	[Panel 1] AI-Powered Drug Discovery and Healthcare Platforms: Human vs AI: Redefining Discovery and Delivery AMPLY Discovery — Biotech (AI tech for lncRNA targets & novel peptide discovery/optimisation in oncology BioCorteX — MedTech (Carbon Mirror™ AI-powered biology emulator for in-silico bridge trials and bacteria-drug interactions) Envisionit Deep AI — Health Tech (RATIFY real-time AI assurance, monitoring and regulatory platform for medical imaging AI) NeuroCreate — MedTech (AI tech for brain health) Moderator: Ms Scarlett Chen, Managing Partner, Verge HealthTech Fund
15:30-15:45	Networking Break
15:45-16:15	[Panel 2] Innovative Diagnostics and Medical Devices: From Improving Detection to Making Smarter Decision EveryBaby — Medical Devices (Preterm birth diagnostics) Guilford Street Laboratories* — AI-powered biomarker assays and multi-omics precision diagnostics Neurovalens — Medical Devices (Non-invasive neurostimulation devices for chronic insomnia) Reacta Healthcare — Medical Devices (Pharmaceutical-grade food allergy challenge materials and diagnostics) SleepUp — MedTech / Digital Therapeutics (Clinically validated platform for sleep disorders) Moderator: Dr Lydia Leung, CEO, Belun Technology
16:15-16:45	[Panel 3] Novel and Precision Therapeutics: Expanding the Therapeutic Toolbox Brain Feed Therapeutics — Biotech (Precision metanutrigenetics metabolite therapeutics for mental health) Laverock Therapeutics* — Biotech (Programmable cell and gene therapies) Neobe Therapeutics* — Synthetic biology (Engineered live bacterial therapeutics for solid tumour microenvironment remodelling and immunotherapy enhancement) VasoDynamics — Pharmaceutical (Topical therapies to prevent chemotherapy/ radiotherapy side effects) Moderator: Ms Lisa Cai, Portfolio Manager — Pivotal Life Sciences; Director, Group CEO Office, Nan Fung Group
16:45-17:00	Networking Break
17:00-17:30	Fireside Chat: From Innovation to Collaboration — Opportunities, Challenges and Pathways Ms Lisa Cai, Portfolio Manager — Pivotal Life Sciences; Director, Group CEO Office, Nan Fung Group Dr Iain Foulkes*, Executive Director of Research & Innovation, Cancer Research UK; CEO, Cancer Research Horizons, UK Mr Emmanuel Hui, CEO, Tiger Jade Pebble Accelerator Prof Stephanie Ma, Vice-President and Pro-Vice-Chancellor (Research); Jimmy and Emily Tang Professor in Molecular Genetics, The University of Hong Kong Mr Ed Tam, Managing Director, New Frontier Group; CEO, United Family Healthcare International Medical Service; Vice-Chairman, New Frontier Group (Hong Kong)
17:30-17:55	Closing Remarks Mr Andy Wong, Head of Innovation and Technology and Life & Health Sciences, Invest Hong Kong
17:35-18:30	Networking over wines, drinks and canapés